Viewing Study NCT00068094



Ignite Creation Date: 2024-05-05 @ 11:30 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00068094
Status: TERMINATED
Last Update Posted: 2006-08-18
First Post: 2003-09-05

Brief Title: The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics
Sponsor: National Center for Complementary and Integrative Health NCCIH
Organization: National Center for Complementary and Integrative Health NCCIH

Study Overview

Official Title: The Effect of a Probiotic on Hepatic Steatosis
Status: TERMINATED
Status Verified Date: 2006-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine whether probiotics bacteria that may improve liver health can effectively treat a chronic condition in diabetics that increases fat in the liver
Detailed Description: Nonalcoholic fatty liver disease NAFLD is the most common cause of chronic liver disease in the United States and is also common in diabetics unfortunately research on NAFLD has been limited Safe inexpensive and well-tolerated treatments for NAFLD are needed Recent studies indicate that probiotics help to improve fat breakdown in mice This study will evaluate the efficacy of probiotic therapy to reduce fat accumulation in the livers of people with NAFLD and diabetes

Participants in this study will be randomly assigned to receive either a probiotic-containing mixture or placebo once daily for 6 months Blood tests and magnetic resonance spectroscopy will be used to assess participants at study start and at study completion

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None